A biopharmaceutical company developing antibody radionuclide conjugates for haematological cancers with their lead molecule Betalutin in Phase I and IIb studies.

Location

Grafenauweg 10, 6300 Zug, Switzerland

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    2009
  • Number of employees in Switzerland
    1-9
Key business